Citius Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Citius Pharmaceuticals

12/05/2023 22:02

* Citius Pharmaceuticals Inc  CTXR.OQ  reported a quarterly
adjusted loss of 7 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 4 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Citius Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 7 cents​.
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Citius Pharmaceuticals Inc shares had risen by 12.8% this
quarter and gained 67.1% so far this year.
    * The company reported a quarterly loss of $10.53 million.
    * Wall Street's median 12-month price target for Citius
Pharmaceuticals Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.03          -0.07          Missed
 Sep. 30 2022      -0.04          -0.05          Missed
 Jun. 30 2022      -0.05          -0.06          Missed